ENTITY
Shionogi & Co

Shionogi & Co (4507 JP)

103
Analysis
Health CareJapan
Shionogi & Company Ltd., is a pharmaceutical company. The Company develops prescription & over-the-counter drugs and diagnostics.
more
bullishShionogi & Co
14 Oct 2024 08:30

Shionogi & Co (4507 JP): Performance to Improve in H2; Upcoming Drugs to Accelerate Growth

​Shionogi reiterates FY25 guidance, showing improved financial performance in Q2FY25 and H2FY25. The company has acquired distribution rights for...

Logo
363 Views
Share
11 Mar 2024 21:23

Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener

We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...

Logo
333 Views
Share
bullishSumitomo Pharma
19 May 2022 19:25

Sumitomo Dainippon Pharma Co (4506 JP): New Launches Ensure Post-Latuda Growth Trajectory

Sumitomo is on right track to alleviate patent cliff through new launches in the U.S. The company’s three new U.S. products have potential for...

Logo
395 Views
Share
bearishEisai Co Ltd
21 Nov 2024 09:30

Eisai Co Ltd (4523 JP): Mixed H1FY25 Performance; Guidance Reaffirmed; Leqembi Struggle Continues

​Eisai sees revenue growth but profit decline in H1FY25. The company reduced Leqembi guidance for FY25. Leqembi is expected to be approved in...

Logo
223 Views
Share
bullishSumitomo Pharma
05 Nov 2024 23:47

Sumitomo Pharma (4506 JP): Challenges Remain, But Slowly Getting There; North America Remains Key

​Sumitomo Pharma sees revenue growth in H1FY25, while losses are narrowing due to restructuring. The company is expected to report profit in H2FY25...

Logo
228 Views
Share
x